DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,888 | +7.2% | 47,915 | +3.7% | 0.06% | +7.8% |
| Q2 2023 | $11,091 | -10.0% | 46,210 | -5.5% | 0.05% | -15.0% |
| Q1 2023 | $12,329 | -11.6% | 48,915 | -6.9% | 0.06% | -16.7% |
| Q4 2022 | $13,940 | -99.9% | 52,521 | +5.3% | 0.07% | -1.4% |
| Q3 2022 | $12,885,000 | +4.8% | 49,884 | +2.9% | 0.07% | +10.6% |
| Q2 2022 | $12,294,000 | -13.8% | 48,494 | -0.2% | 0.07% | +1.5% |
| Q1 2022 | $14,256,000 | -2.4% | 48,600 | +9.4% | 0.06% | 0.0% |
| Q4 2021 | $14,611,000 | +14.3% | 44,410 | +5.7% | 0.06% | +3.2% |
| Q3 2021 | $12,788,000 | +7.4% | 42,005 | -5.3% | 0.06% | +10.5% |
| Q2 2021 | $11,904,000 | -15.1% | 44,360 | -28.8% | 0.06% | -25.0% |
| Q1 2021 | $14,025,000 | +5.6% | 62,313 | +4.2% | 0.08% | -2.6% |
| Q4 2020 | $13,285,000 | +68.0% | 59,806 | +62.9% | 0.08% | +47.2% |
| Q3 2020 | $7,907,000 | +29.6% | 36,722 | +6.4% | 0.05% | +15.2% |
| Q2 2020 | $6,102,000 | +17.7% | 34,505 | -7.9% | 0.05% | -8.0% |
| Q1 2020 | $5,185,000 | +12.9% | 37,460 | +25.2% | 0.05% | +42.9% |
| Q4 2019 | $4,594,000 | +9.6% | 29,932 | +3.1% | 0.04% | -5.4% |
| Q3 2019 | $4,191,000 | +4.3% | 29,020 | +3.2% | 0.04% | 0.0% |
| Q2 2019 | $4,020,000 | +8.7% | 28,129 | +0.4% | 0.04% | +5.7% |
| Q1 2019 | $3,697,000 | +28.0% | 28,006 | -0.0% | 0.04% | +9.4% |
| Q4 2018 | $2,889,000 | -16.5% | 28,017 | -12.0% | 0.03% | -3.0% |
| Q3 2018 | $3,459,000 | +32.0% | 31,836 | +19.9% | 0.03% | +17.9% |
| Q2 2018 | $2,621,000 | +17.0% | 26,557 | +16.0% | 0.03% | +12.0% |
| Q1 2018 | $2,241,000 | +59.5% | 22,892 | +51.2% | 0.02% | +47.1% |
| Q4 2017 | $1,405,000 | -0.8% | 15,141 | -8.4% | 0.02% | -10.5% |
| Q3 2017 | $1,417,000 | +26.9% | 16,523 | +24.9% | 0.02% | +18.8% |
| Q2 2017 | $1,117,000 | 0.0% | 13,234 | +1.4% | 0.02% | -15.8% |
| Q1 2017 | $1,117,000 | +17.5% | 13,054 | +6.9% | 0.02% | +5.6% |
| Q4 2016 | $951,000 | -18.2% | 12,214 | -17.6% | 0.02% | -18.2% |
| Q3 2016 | $1,162,000 | -16.7% | 14,820 | +7.3% | 0.02% | -26.7% |
| Q2 2016 | $1,395,000 | +12.6% | 13,807 | +5.7% | 0.03% | +7.1% |
| Q1 2016 | $1,239,000 | +3.8% | 13,059 | +1.6% | 0.03% | 0.0% |
| Q4 2015 | $1,194,000 | +15.4% | 12,859 | +5.9% | 0.03% | -6.7% |
| Q3 2015 | $1,035,000 | -1.6% | 12,147 | -1.1% | 0.03% | +3.4% |
| Q2 2015 | $1,052,000 | +1.6% | 12,286 | +0.8% | 0.03% | 0.0% |
| Q1 2015 | $1,035,000 | -4.3% | 12,193 | -3.4% | 0.03% | -14.7% |
| Q4 2014 | $1,082,000 | +11.0% | 12,626 | -1.6% | 0.03% | +17.2% |
| Q3 2014 | $975,000 | -1.9% | 12,835 | +1.7% | 0.03% | -17.1% |
| Q2 2014 | $994,000 | +5.5% | 12,622 | +0.5% | 0.04% | -2.8% |
| Q1 2014 | $942,000 | +29.2% | 12,554 | +32.9% | 0.04% | +20.0% |
| Q4 2013 | $729,000 | +10.8% | 9,447 | -0.4% | 0.03% | +3.4% |
| Q3 2013 | $658,000 | +29.5% | 9,486 | +18.2% | 0.03% | +11.5% |
| Q2 2013 | $508,000 | – | 8,028 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |